CANF
Can-Fite BioPharma
CANF
CANF
11 hedge funds and large institutions have $1.62M invested in Can-Fite BioPharma in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AC
1
Armistice Capital
New York
|
$1.34M |
2 |
2
Morgan Stanley
New York
|
$175K |
3 |
HF
3
HRT Financial
New York
|
$27K |
4 |
VF
4
Virtu Financial
New York
|
$27K |
5 |
AWM
5
Activest Wealth Management
Aventure,
Florida
|
$516 |
Top Sellers
1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
2 |
![]()
2
RhumbLine Advisers
Boston,
Massachusetts
|
$39.7K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$0 |